Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 248: Incentives to Stop AIDS and HIV in Drug Users
A randomized clinical trial evaluating the role of contingent reinforcement in the engagement and retention of Drug Users in HAART programs: a substudy of CTN 244
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 244: STOP HIV & AIDS in IDU
Seek and Treat for Optimal outcomes and Prevention in HIV & AIDS in IDU
-
-
CTN 222: Canadian co-infection cohort
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients
-
CTN 253: H1N1 flu vaccine study in HIV-positive adults
PCIRN evaluation of pandemic H1N1 (2009) influenza vaccine in adults with human immunodeficiency virus infection
-
CTN 246: Chloroquine to reduce T cell immune activation in HIV-infected individuals
Chloroquine as a modulator of T cell immune activation to improve CD4 recovery in HIV-infected participants receiving antiretroviral therapy: A proof-of-concept study
-
CTN 242: Canadian observational cohort (CANOC) collaboration
Please Note: This is an observational study and is designed to examine and link HIV/AIDS information drawn from databases across Canada
-
CTN 238: The MAINTAIN study
A randomized control clinical trial of micronutrient and antioxidant supplementation in persons with untreated HIV infection
-
CTN 236: HPV vaccine in HIV positive girls and women
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
-
CTN 233: Pharmacokinetics of antiretroviral therapy (ARV) in HIV-positive women
Predictors of antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy
-
CTN 216: Argon plasma coagulation for anal dysplasia in MSM
A Phase II, prospective, open-label, pilot study of the tolerability, safety, and efficacy of Argon plasma coagulation for the treatment of anal intraepithelial neoplasia grade 2 or 3 in HIV-positive men having sex with men
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More